JPS6121527B2 - - Google Patents
Info
- Publication number
- JPS6121527B2 JPS6121527B2 JP3415780A JP3415780A JPS6121527B2 JP S6121527 B2 JPS6121527 B2 JP S6121527B2 JP 3415780 A JP3415780 A JP 3415780A JP 3415780 A JP3415780 A JP 3415780A JP S6121527 B2 JPS6121527 B2 JP S6121527B2
- Authority
- JP
- Japan
- Prior art keywords
- weight
- parts
- external preparation
- observed
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000002360 preparation method Methods 0.000 claims description 23
- SFHUSLFRIKHKPE-UHFFFAOYSA-L chloro-[(2,5-dioxoimidazolidin-4-yl)carbamoylamino]aluminum;hydrate Chemical compound O.NC(=O)NC1NC(=O)N([Al]Cl)C1=O SFHUSLFRIKHKPE-UHFFFAOYSA-L 0.000 claims description 16
- 239000000843 powder Substances 0.000 claims description 15
- 208000004210 Pressure Ulcer Diseases 0.000 claims description 9
- 238000011282 treatment Methods 0.000 claims description 8
- 230000000694 effects Effects 0.000 description 11
- 208000027418 Wounds and injury Diseases 0.000 description 10
- 210000003491 skin Anatomy 0.000 description 9
- 229920002261 Corn starch Polymers 0.000 description 8
- 241000700159 Rattus Species 0.000 description 8
- 206010052428 Wound Diseases 0.000 description 8
- 239000008120 corn starch Substances 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- 208000025865 Ulcer Diseases 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 7
- 231100000397 ulcer Toxicity 0.000 description 6
- 210000000416 exudates and transudate Anatomy 0.000 description 5
- 239000002674 ointment Substances 0.000 description 5
- 230000035876 healing Effects 0.000 description 4
- 230000007794 irritation Effects 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 230000029663 wound healing Effects 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000034994 death Effects 0.000 description 3
- 231100000517 death Toxicity 0.000 description 3
- 238000001647 drug administration Methods 0.000 description 3
- 230000037305 epidermis formation Effects 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 238000007912 intraperitoneal administration Methods 0.000 description 3
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 3
- 239000001095 magnesium carbonate Substances 0.000 description 3
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000007059 acute toxicity Effects 0.000 description 2
- 231100000403 acute toxicity Toxicity 0.000 description 2
- 229940024546 aluminum hydroxide gel Drugs 0.000 description 2
- SMYKVLBUSSNXMV-UHFFFAOYSA-K aluminum;trihydroxide;hydrate Chemical compound O.[OH-].[OH-].[OH-].[Al+3] SMYKVLBUSSNXMV-UHFFFAOYSA-K 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 230000007665 chronic toxicity Effects 0.000 description 2
- 231100000160 chronic toxicity Toxicity 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 210000004400 mucous membrane Anatomy 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 231100000820 toxicity test Toxicity 0.000 description 2
- XOOUIPVCVHRTMJ-UHFFFAOYSA-L zinc stearate Chemical compound [Zn+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O XOOUIPVCVHRTMJ-UHFFFAOYSA-L 0.000 description 2
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000031648 Body Weight Changes Diseases 0.000 description 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 1
- WJLVQTJZDCGNJN-UHFFFAOYSA-N Chlorhexidine hydrochloride Chemical compound Cl.Cl.C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 WJLVQTJZDCGNJN-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000004579 body weight change Effects 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229960003333 chlorhexidine gluconate Drugs 0.000 description 1
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 1
- 229960004504 chlorhexidine hydrochloride Drugs 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 210000000795 conjunctiva Anatomy 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 238000011866 long-term treatment Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000003883 ointment base Substances 0.000 description 1
- 229940056211 paraffin Drugs 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- GRLPQNLYRHEGIJ-UHFFFAOYSA-J potassium aluminium sulfate Chemical compound [Al+3].[K+].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GRLPQNLYRHEGIJ-UHFFFAOYSA-J 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 229940116317 potato starch Drugs 0.000 description 1
- 229940088417 precipitated calcium carbonate Drugs 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- -1 rice starch Substances 0.000 description 1
- 229940100486 rice starch Drugs 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 231100000456 subacute toxicity Toxicity 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 229940033134 talc Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 229940100445 wheat starch Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 235000014692 zinc oxide Nutrition 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3415780A JPS56131517A (en) | 1980-03-19 | 1980-03-19 | Preparation for external use |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3415780A JPS56131517A (en) | 1980-03-19 | 1980-03-19 | Preparation for external use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS56131517A JPS56131517A (en) | 1981-10-15 |
| JPS6121527B2 true JPS6121527B2 (sk) | 1986-05-27 |
Family
ID=12406362
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP3415780A Granted JPS56131517A (en) | 1980-03-19 | 1980-03-19 | Preparation for external use |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS56131517A (sk) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61168355A (ja) * | 1984-09-13 | 1986-07-30 | 原ヘルス工業株式会社 | 防水ラジオ及びデジタル時計付き健康風呂装置 |
| JPH025783Y2 (sk) * | 1984-09-05 | 1990-02-13 | ||
| JPH03184Y2 (sk) * | 1986-03-10 | 1991-01-08 | ||
| JPH0316658Y2 (sk) * | 1986-03-14 | 1991-04-10 | ||
| JPH05198Y2 (sk) * | 1987-12-30 | 1993-01-06 | ||
| JPH05196Y2 (sk) * | 1987-12-16 | 1993-01-06 | ||
| JPH05197Y2 (sk) * | 1987-12-16 | 1993-01-06 | ||
| JPH056988Y2 (sk) * | 1987-12-16 | 1993-02-23 | ||
| JPH056987Y2 (sk) * | 1987-12-16 | 1993-02-23 |
-
1980
- 1980-03-19 JP JP3415780A patent/JPS56131517A/ja active Granted
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH025783Y2 (sk) * | 1984-09-05 | 1990-02-13 | ||
| JPS61168355A (ja) * | 1984-09-13 | 1986-07-30 | 原ヘルス工業株式会社 | 防水ラジオ及びデジタル時計付き健康風呂装置 |
| JPH03184Y2 (sk) * | 1986-03-10 | 1991-01-08 | ||
| JPH0316658Y2 (sk) * | 1986-03-14 | 1991-04-10 | ||
| JPH05196Y2 (sk) * | 1987-12-16 | 1993-01-06 | ||
| JPH05197Y2 (sk) * | 1987-12-16 | 1993-01-06 | ||
| JPH056988Y2 (sk) * | 1987-12-16 | 1993-02-23 | ||
| JPH056987Y2 (sk) * | 1987-12-16 | 1993-02-23 | ||
| JPH05198Y2 (sk) * | 1987-12-30 | 1993-01-06 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS56131517A (en) | 1981-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4555524A (en) | Transdermal 2-(4-isobutylphenyl)-propionic acid medication and methods | |
| SK16582002A3 (sk) | Liečivé produkty s cikatrizačným účinkom obsahujúce biguanidové deriváty | |
| CN108853312A (zh) | 聚桂醇外用凝胶及其制备方法 | |
| US5916918A (en) | Method for treating a skin injury comprising topically applying acetylsalicylic acid | |
| JPS6121527B2 (sk) | ||
| KR101894521B1 (ko) | 흉터치료를 위한 국소용 약학적 조성물 | |
| JP3798168B2 (ja) | 創傷治癒のための局所用薬剤組成物類 | |
| JP3899267B2 (ja) | 皮膚、粘膜、器官または組織の疾患を治療するためのトシルクロルアミドの使用 | |
| RU2184538C2 (ru) | Применение дихлорбензилового спирта для получения лекарственного средства для местного лечения воспаления и лекарственное средство, содержащее дихлорбензиловый спирт | |
| JPH039885B2 (sk) | ||
| JP3877807B2 (ja) | 口内炎治療・予防剤 | |
| JP2860550B2 (ja) | 急性皮膚炎症治療剤 | |
| JPS6361287B2 (sk) | ||
| JPS6045161B2 (ja) | 熱傷の治療剤 | |
| JPH1149672A (ja) | 創傷治療用外用剤 | |
| RU2200550C2 (ru) | Новые лекарственные формы димоцифона в терапии лепры, зудящих и аллергодерматозов, герпетиформного дерматита дюринга | |
| HU207446B (en) | Method for producing medicinal preparation of local use | |
| JPH09235232A (ja) | アセチルサリチル酸含有皮膚損傷治療剤 | |
| RU2040256C1 (ru) | Средство для лечения травматического артрита | |
| JPS6191120A (ja) | 創傷の治療剤 | |
| JP2023518430A (ja) | 感染症の治療におけるブシラミンの使用 | |
| IL255544A (en) | Clonidine and / or Clonidine derivatives for use in the prevention of skin damage resulting from radiotherapy | |
| Agius et al. | The value of colloid dressings in psoriasis | |
| US20190000822A1 (en) | Chlorine or bromine salts of cetylpyridinium for use in the treatment of cutaneous and acute porphyrias and psoriasis | |
| JPS6191121A (ja) | 創傷治療剤 |